Rays of hope for development of materials for 3D displays and medical applications

Chiral molecules are mirror images of one another. They are non-superimposable and play a crucial role in advanced materials and technologies. However, there had been no reliable theoretical systems for the design and synthesis of chiral materials. These systems had seen only gradual development, with chemists making progress on the design and synthesis of chiral materials based on their intuition.

A research group led by Tadashi Mori at Osaka University aligned two hexahelicenes in various orientations, theoretically examined, and proposed that S- and X-shaped double hexahelicenes aligned in right symmetry were a key to improve the properties of helicenes. The researchers then synthesized double hexahelicenes to demonstrate their improved chiroptical properties as chiral materials: circular dichroism (CD) and circularly polarized luminescence (CPL). Their research results were published in Communications Chemistry.

They aligned multiple chiral hexahelicene units to thoroughly examine how their chiroptical properties would be enhanced by quantum chemical calculations. The results suggested that chiroptical performances were enhanced in S- and X-shaped helicenes aligned in right symmetry.

The researchers also examined the number of molecules to be aligned and the space between molecules and found the possibility that double helicenes, in which two helicenes are merged, could become ideal chiral materials.

Based on the discussion stated above, employing X- and S- shaped pristine double hexahelicenes (DNH and DPC) as representative molecular models, this group synthesized both double hexahelicenes, demonstrating drastic improvement of their chiroptical properties.

They pursued what factors control chiroptical responses and found that both intensity and orientation of the electric and magnetic transition dipole moments of the molecules were important.

This group demonstrated the new logical protocol for designing chiral materials: how to rationally align and design molecules. By using strategies beyond conventional ways of material development that were based on researchers’ intuition, the group drastically improved material development costs. Polarized light can be used for next-generation optical information technology, so this study will accelerate technical innovation in the development of advanced materials for 3D displays and endoscopes in medical applications, as well as security paint in information and communication fields.

Story Source:

Materials provided by Osaka University. Note: Content may be edited for style and length.

Share Button

Billy Caldwell: Emergency medicine licence enables boy to return to NI

NI health department issues emergency licence allowing doctors to treat young boy with medicinal cannabis.

Share Button

Swansea beach BBQ burns skin off feet of boy aged two

“His blisters had to be burst and the damaged skin scraped off,” the boy’s mother said.

Share Button

Health24.com | Former president Zuma’s son died from lupus complications, but what is it?

A family representative confirmed the cause of death of former president Jacob Zuma’s son Vusi Nhlakanipho Zuma was related to complications from lupus. He died on 1 July 2018.

The condition, formally known as systematic lupus erythematosus, is characterised by chronic inflammation.

It causes the body’s defence system to attack its own tissue and organs, such as the skin, kidneys, lungs and the brain, potentially leading to organ failure.

While lupus can affect anyone, it is believed to affect women more than men and, according to Lupus Research Alliance, women of colour are even more likely to be diagnosed with the illness.

There isn’t a definite answer to how someone develops lupus, but researchers have looked into various factors in an attempt to answer the question of what actually causes it?

The Resource Centre on Lupus says that there is a combination of factors which may cause lupus to develop and this includes hormones, genetics and your environment.

Symptoms of lupus include:

  • A high fever
  • Bouts of fatigue
  • Pain or swelling in the joints (fingers, hands, knees, wrists, shoulders and hips) due to arthritis
  • Skin rashes, especially if it’s the “butterfly” rash, officially known as the malar rash, which develops on the bridge of the nose and the cheeks due to sun exposure. Other lesions may develop on parts of the body exposed to sunlight.

Health24 has documented an extensive list of common and less common symptoms associated with the disease.

There is no cure for lupus, but specialists will prescribe medication to combat the symptoms.

Several celebrities have been diagnosed with the disease, including Toni Braxton, Seal and Selena Gomez, who recently had a kidney transplant – her close friend, Francia Raisa, was her donor. 

Image credit: iStock

Share Button

Health24.com | Medical aid members getting a raw deal, Competition Commission finds after lengthy probe

Cape Town – The Competition Commission has found that medical aid members have been getting a raw deal and now schemes and healthcare providers have two months to respond to recommendations – that there be changes to the way the private healthcare sector operates and that medical aids clarify their offerings.

The Competition Commission, in its findings on a four-year investigation into South Africa’s private healthcare sector titled the Healthcare Market Inquiry released on Thursday, found that new interventions are needed because the current system is not competitive, medical aids are making huge profits and consumers are not getting fair value for their money.

The Commission initiated the inquiry into the rocketing costs of private healthcare by looking into the work of doctors and specialists, the role of new technologies and developments in the sector, hospital network operations and how medical aids present themselves to members in terms of their offerings and options.

The key problems with the current system were not primarily identified as the spiraling costs of medical aid cover, but rather overcapacity and over-investment in technology, higher treatment volumes and more complex, intensive and expensive treatment methods than patients need.

The inquiry found that practitioners, as the usual point of entry into the health care market due to their superior knowledge, act as agents for consumers.

In doing so they drive healthcare expenditure through their own activities, such as diagnoses and treatment, and through the services and treatments they recommend. These would include referrals for further investigation, treatment and hospitalisation.

This is happening in a market “replete with perverse incentives”.

General practitioners were found to form independent practice associations to promote preferred networks – with the information not made public, no peer review systems and no evidence of consequences for doctors who fail to meet satisfactory quality levels.

Specialists were found to also form associations to collectively resist joining preferred provider networks, while pushing up their prices without adding value.

The current pricing environment was found to be unregulated with an alignment of interests between facilities and practitioners so that both benefit from higher volumes, while the uninformed patient remains unaware of the long term financial impact this has on medical aid cover.

The Competition Commission found that, with approximately 270 plans on offer, consumers are not able to compare offerings, nor can they choose scheme and plan options on the basis of value-for-money. This confusing bundling, packaging and pricing was deliberate in order to allow medical schemes to weaken, even avoid, outright price competition.

“The absence of competitive pressure is primarily due to disempowered and uninformed consumers. There is no method for consumers to assess the value of the services that schemes procure on their behalf.

Without understanding this, consumers cannot hold trustees and Principal Officers to account. Consequently, trustees and Principal Officers experience no pressure to hold administrators and managed care organisations to account,” the report found.

There are currently 22 open medical schemes, with only two schemes constituting approximately 70% of the total open scheme market. Discovery Health Medical Scheme (DHMS) comprises 55% of the open scheme market and continues to grow organically and through a series of amalgamations with smaller restricted schemes. The Government Employees Medical Scheme (GEMS) is the largest restricted scheme and second only to DHMS on the number of beneficiaries.

The administrator market is also highly concentrated with 16 administrators in total, and Discovery Health and Medscheme accounting for 76% of the contribution income.

“We have observed no meaningful entry in the funders market over at least a decade. Competition could be much more improved if transparency, accountability, supplier-induced oversupply of care and value-driven healthcare were priorities of scheme trustees and administrators,” the Inquiry found. 

“We have not noted any existing players seriously challenging the dominant players… Some of the broker arrangements within these groups have the effect of blurring the lines between medical scheme and other insurance products and services.”

The Commission said Discovery Health has consistently earned profits well above its main competitors, with no sign of challenge. This could be attributed to good management, but did not fully explain the massive profitability gap as Discovery did not source services from any other industry stakeholder, risk selection and broker management to contribute to its profitability.

“We see Discovery Health growing and becoming more successful over time. This is an indication of market failure and there are no signals that the market will self-correct,” the Inquiry found.

The top three administrators (Discovery Health, Medscheme and MMI) all failed to negotiate consistently better tariffs.

“One of the most important consequences of the dominance of the three large hospital groups (Netcare, Mediclinic and Life) is that no funder can afford not to contract with any one of the three big facility groups, or to totally exclude one of these groups from any provider networks.”

This means hospital profitability has been consistent and sustained and consumers left exposed as they are unable to choose between scheme options or service providers. 

Stakeholders have been given until September 7 to comment or propose recommendations on the report.

– Health-e News

NEXT ON HEALTH24X

Share Button

Health24.com | How to store your allergy meds

In order for medications to remain effective until their expiry date, they need to be stored correctly – regardless of the diseases or conditions they’re intended to treat or prevent.

This is important in the case of allergy medication as a severe allergic reaction can lead to anaphylactic shock and even death if not treated in time.

General rules for storing medication

There are a number of factors that can affect your medication. Storing your medications under the wrong conditions can make them ineffective or even harmful.

Every medication is different and may have its own special storage requirements – whether at room temperature, in the fridge or freezer. It is therefore advisable to check for any specific storage instructions on the packaging or from your pharmacist. The following are general rules:

  • Store at room temperature (15 to 25°C). Temperature is especially important in the case of insulin.
  • Store in a dry place.
  • Avoid storing your medicine in the bathroom or kitchen, as the heat and moisture in these rooms may cause damage to your medication. Your bedroom is a better place.
  • Keep all medicines out of sight and reach of children and pets.
  • Don’t use medicines beyond their expiry date.
  • Keep the original containers as they generally contain instructions and are designed for optimal storage.
  • Keep your medication organised.
  • Don’t keep different medications in a single container.
  • When travelling by plane, take your medications with you into the cabin. This ensures more stable temperatures and moisture levels. (Your medicine is also less likely to get lost.)  


Most common allergy treatments

Allergies cannot be cured; therefore the function of most allergy medications is to relieve or reverse symptoms. (Bear in mind that although most allergy medications are for self-administration, some should only be administered by trained medical professionals.)  

According to a previous Health24 article, the most common of these treatments are:

1. Antihistamines block the release of histamine by the body’s mast cells. Antihistamines are used to treat symptoms like sneezing, watery eyes, hives and a runny nose, and are available in different forms, including tablets, capsules, liquids, syrups, creams, lotions, gels, eye drops and nasal sprays.

  • Tablets (pills) and capsules are easily damaged by heat and moisture. Aspirin pills, for example, break down into vinegar and salicylic acid, which can irritate the stomach.
  • Most medicinal liquids and syrups need to stored at around 15 to 30°C, which means that it’s best not to store liquid medication in the fridge. When in doubt, refer to storage instructions on the bottle or packaging.  
  • Eye drops should be stored at an optimum temperature and out of sunlight. When the bottle is opened there is contamination risk through human contact, dust particles or fungal and bacterial spores. 
  • In the case of nasal sprays, refer to storage information on the package. Protect from heat and light. Remember to discard the product properly when it has expired or is no longer needed.

2. Decongestants shrink swollen nasal tissues, thereby relieving congestion. Decongestants are available as nasal sprays, tablets or capsules, liquids, syrups or flavoured powders that dissolve in water.

  • Powdered medicine needs to stored in a low-humidity, low-temperature location. Moisture is especially damaging to powders that dissolve quickly. 

3. Steroids control inflammation and stop allergic reactions. Corticosteroid preparations have anti-inflammatory and immunosuppressive properties and are widely used in the treatment of asthma and allergic disorders. Steroids can be given locally or systemically (throughout the body).

Examples of local steroid treatments include joint injections, eye drops, ear drops and skin creams. Systemic steroid treatments include oral medicines (given by mouth) or medicine that is delivered directly into a vein (intravenously or IV) or muscle (intramuscularly).

  • Injections and drips are usually administered by trained medical staff. The main exception is insulin, which should be kept in the refrigerator (between 2.2°C and 7.7°C). Keep or use until the expiration date.

4. Topical creams or skin ointments are used to treat eczema. The most common topical treatments include prescription steroids in varying strengths, calcineurin inhibitors and PDE4 inhibitors.

  • High temperatures can melt ointments and creams, making them ineffective. It is therefore especially important to keep these products away from sunlight. The same applies to lotions and gels.

5. Immunotherapy or allergy injections can gradually build up tolerance to the allergenic substance so that the body no longer reacts to it. Whether in the form of shots or tablets, immunotherapy desensitises the body to specific allergens that trigger allergy symptoms.

6. Antibiotics may also be necessary to treat complications such as ear and sinus infections common in children with allergies. Antibiotics can be administered intravenously (drip or injection) or orally (tablets).

7. Epinephrine autoinjector reverses anaphylactic shock. EpiPen® gives the following specific recommendations:            

  • Always store in the carrier tube with the safety release on until you need to use it.
  • Keep at room temperature. Do not refrigerate.
  • Can be exposed to temperatures between 15° to 30°C.
  • Do not keep in a vehicle during extremely hot or cold weather.
  • Protect from light.
  • Regularly check viewing window and replace if solution is brown, discoloured or cloudy.

Image credit: iStock

Share Button

‘I’ve been an NHS patient for 70 years’

Patients, politicians and celebrities pay tribute to the NHS as it marks its 70th anniversary.

Share Button

Fitness Expert Anna Victoria Shares Photo of Her Arm Cellulite: ‘Stop Thinking You’re the Only One’

This article originally appeared on People.com. 

Fitness influencer Anna Victoria is known to speak honestly about her body, and now she’s opening up about her cellulite.

Victoria, co-founder of the Fit Body Guide, took to Instagram earlier this week to post side-by-side photos of herself, one in “the best possible lighting” and the other in lighting that highlighted cellulite on her arm.

 

“Lighting. Is. Everything. 99% of pictures you see on social media are taken in the best possible lighting and that ain’t no accident,” Victoria wrote alongside the photos.

“When I got into the elevator with the lighting on the right, I zoned in on the cellulite on the back of my arms,” she continued. “Yes, cellulite on your arms is a thing! I’ve had it since the beginning of my journey and while it’s lightened up since then, it’s still not totally gone … because I’m human.”

[brightcove:4874680285001 default]

The lengthy post has garnered a lot of attention, amassing more than 30,000 Likes in just one day, along with several comments.

Victoria noted alongside the photo that although the appearance of cellulite can be reduced through a “healthy diet, regular exercise and proper water intake,” genetics also play a part in dimpling skin.

“Seriously, girls, stop thinking you’re the only one with cellulite and that it’s some kind of disease,” the trainer said. “Do I love the look of my arms on the right? No, but I don’t hate it or hate myself for it, either. And you shouldn’t either.”

 

Share Button

Health24.com | Would you trust a doctor with tattoos?

Doctors need not fear that sporting a tattoo might drive patients away.

Patients’ evaluation

That’s the finding of a small, new study that included seven doctors in the emergency department of a trauma centre in a large Pennsylvania city who wore either fake body piercings or tattoos, or both, or no body art at all.

The researchers surveyed nearly 1 000 adult patients after a consultation with one of the doctors. Specifically, the patients were asked about their views on their doctor’s competence, professionalism, caring attitude, approachability, trustworthiness and reliability.

The patients rated all five qualities highly more than 75% of the time, whether or not they were treated by a doctor with visible body art. Age, gender, education levels and ethnicity also did not seem to have any effect on the patients’ responses, the findings showed.

The study authors, led by Dr Rebecca Jeanmonod from St. Luke’s University Health, didn’t ask patients whether they had body art themselves, or whether they disapproved of it. And ER patients may not be like other types of patients, the researchers acknowledged.

Still, “physician tattoos and facial piercings were not factors in patients’ evaluations of physician competence, professionalism or approachability,” the researchers reported.

The study was published online in the Emergency Medicine Journal.

At least one tattoo

While previous studies have indicated that patients prefer doctors in traditional attire, they were based mainly on photos and written descriptions. Few involved actual interaction between patients and doctors, according to the researchers behind the new study.

The study team also noted that tattoos and piercings are becoming increasingly common. In 2016, more than one-third of young US adults, and four out of 10 of those aged 26 to 40 said they had at least one tattoo. In 2014, the rate of body piercings was 14%.

“Given these statistics, those who enter the medical field today are more likely to have body art than medical professionals did previously,” the study authors wrote in a journal news release. “Despite this, dress codes and institutional policies at most hospitals still prohibit medical professionals from having visible body art.”

Image credit: iStock

Share Button

To help save northern spotted owls, we need to prevent kissing cousins

The Auk: Ornithological Advances presents a study on a Northern Spotted Owl pedigree, consisting of almost 14,200 individuals over 30 years, which determined inbreeding varies across the species’ range. Selection against inbreeding based on decreased future reproduction, fewer offspring, and overall survival of individuals was also supported. These results indicate that Spotted Owl conservation efforts need to address owl breeding more. Another implication of this work is the need to increase genetic diversity to prevent further population decline.

Mark Miller of the United States Geological Survey (USGS) Forest and Rangeland Ecosystem Science Center, and colleagues employed field and statistical methods to create a family tree for Northern Spotted Owls living in California, Oregon, and Washington. From this, the researchers determined how often inbreeding occurs in the wild for these birds. Fourteen types of matings among relatives were determined with most inbreeding relationships being between half or full siblings. It was discovered that inbreeding is most common in the Washington Cascades (~15% of individuals are inbred), while the lowest inbred population was Northern California (~2.7% of individuals). The explanation for this geographic variation may be the rate at which specific populations are declining and experiencing bottlenecks. Conservation efforts are vital today given that Northern Spotted Owls are already facing habitat loss and competition with a similar species, the Barred Owl. This study showed that both the physical consequences of inbreeding (physical deformities, reduced ability to adapt) and the reproductive fitness of individual birds (infertility, future reproduction, decreased survival) need to be taken into account since both influence this species’ success. Translocating birds among populations to help increase the genetic diversity may be a potential management strategy.

Lead author Mark Miller comments, “Long-term studies, similar to the one described in this paper, are key to understanding how common or rare inbreeding is in natural populations. An understanding of the extent of inbreeding can help resource managers better identify appropriate measures to conserve threatened and endangered species.”

Story Source:

Materials provided by American Ornithological Society Publications Office. Note: Content may be edited for style and length.

Share Button